| Biotechnology Industry | Healthcare Sector | Mr. Gang Zhu CEO | SSE Exchange | CNE100002RR9 ISIN |
| CN Country | - Employees | 18 Jun 2026 Last Dividend | 1 Jun 2018 Last Split | - IPO Date |
Getein Biotech, Inc. is a prominent entity in the biotechnology industry, focused on the research, development, production, and international sales of in vitro diagnostic reagents and instruments. Since its inception in 2002, the company has established its headquarters in Nanjing, China, and has made significant strides not only within domestic markets but on an international scale as well. Getein Biotech is dedicated to advancing medical diagnosis through innovation, offering a wide range of diagnostic solutions that cater to various fields such as cardiovascular diseases, inflammation, kidney functions, and more. Its comprehensive approach in providing quality diagnostic products and services addresses the needs of various healthcare settings, ranging from laboratory departments and emergency rooms to health examination centers and home health management.
Getein Biotech, Inc. boasts a diverse portfolio of diagnostic products and services, including but not limited to:
These products and services span across various technical fields and detection areas, including cardiovascular, inflammation, kidney diseases, thyroid function, hormone levels, glucose metabolism, tumors, blood cells, blood coagulation, and more. Their applications are widespread, serving the laboratory departments of medical institutions, emergency rooms, health examination centers, community clinics, and even for personal health management at home.